Bibliografia

1. Grimby G, Ekholm J. Rehabilitation research after year 2000 – a review from a panel discussion. J Rehabil Med 2001; 33: 50-1.

2. Whyte J, Vaccaro M, Grieb-Neff P et al. Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. J Head Trauma Rehabil 2002; 17: 284-99.

3. Feeney DM, Weisend MP, Kline AE. Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J Neural Transplant Plast 1993; 4: 199-213.

4. Walker-Batson D, Curtis S, Natarajan R et al. A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke 2001; 32: 2093-8.

5. Walker-Batson D, Smith P, Curtis S et al. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 1995; 26: 2254-9.

6. Sonde L, Nordstrom M, Nilsson CG et al. A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke. Cerebrovasc Dis 2001; 12: 253-7.

7. Treig T, Werner C, Sachse M et al. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study. Clin Rehabil 2003; 17: 590-9.

8. Martinsson L, Wahlgren NG, Hardemark HG. Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev 2003; CD002090.

9. Hornstein A, Lennihan L, Seliger G et al. Amphetamine in recovery from brain injury. Brain Inj 1996; 10: 145-8.

10. Forsyth R, Jayamoni B. Noradrenergic agonists for acute traumatic brain injury. Cochrane Database Syst Rev 2003; CD003984.

11. Greener J, Enderby P, Whurr R. Pharmacological treatment for aphasia following stroke. Cochrane Database Syst Rev 2001; CD000424.

12. Ricci S, Celani MG, Cantisani AT et al. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev 2000; CD000419.

13. Enderby P, Broeckx J, Hospers W et al. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study. Clin Neuropharmacol 1994; 17: 320-31.

14. Scheidtmann K, Fries W, Muller F et al. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001; 358: 787-90.

15. Mukand JA, Guilmette TJ, Allen DG et al. Dopaminergic therapy with carbidopa L-dopa for left neglect after stroke: a case series. Arch Phys Med Rehabil 2001; 82: 1279-82.

16. Scheidtmann K. Advances in adjuvant pharmacotherapy for motor rehabilitation: effects of levodopa. Restor Neurol Neurosci 2004; 22: 393-8.

17. Fleet WS, Valenstein E, Watson RT et al. Dopamine agonist therapy for neglect in humans. Neurology 1987; 37: 1765-70.

18. Hurford P, Stringer AY, Jann B. Neuropharmacologic treatment of hemineglect: a case report comparing bromocriptine and methylphenidate. Arch Phys Med Rehabil 1998; 79: 346-9.

19. Barrett AM, Crucian GP, Schwartz RL et al. Adverse effect of dopamine agonist therapy in a patient with motor-intentional neglect. Arch Phys Med Rehabil 1999; 80: 600-3.

20. Geminiani G, Bottini G, Sterzi R. Dopaminergic stimulation in unilateral neglect. J Neurol Neurosurg Psychiatry 1998; 65: 344-7.

21. Berthier ML, Hinojosa J, Martin MC et al. Open-label study of donepezil in chronic poststroke aphasia. Neurology 2003; 60: 1218-9.

22. Berthier ML, Pujol J, Gironell A et al. Beneficial effect of donepezil on sensorimotor function after stroke. Am J Phys Med Rehabil 2003; 82: 725-9.

23. Zhang L, Plotkin RC, Wang G et al. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil 2004; 85: 1050-5.

24. Jorge RE, Robinson RG, Arndt S et al. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003; 160: 1823-9.

25. Gonzalez-Torrecillas JL, Mendlewicz J, Lobo A. Effects of early treatment of poststroke depression on neuropsychological rehabilitation. Int Psychogeriatr 1995; 7: 547-60.

26. Gainotti G, Antonucci G, Marra C et al. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 2001; 71: 258-61.

27. Paolucci S, Antonucci G, Grasso MG et al. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study. Cerebrovasc Dis 2001; 12: 264-71.

28. Dam M, Tonin P, De Boni A at al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996; 27: 1211-4.

29. Pariente J, Loubinoux I, Carel C et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001; 50: 718-29.

30. Laska AC, Von Arbin M, Kahan T et al. Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. Cerebrovasc Dis 2005; 19: 125-32.

31. Goldstein LB. Potential effects of common drugs on stroke recovery. Arch Neurol 1998; 55: 454-6.

32. Troisi E, Paolucci S, Silvestrini M et al. Prognostic factors in stroke rehabilitation: the possible role of pharmacological treatment. Acta Neurol Scand 2002; 105: 100-6.